Condition

KMT2A Rearrangement clinical trials and research

As of November 12, 2026, Find a Trial lists 3 KMT2A Rearrangement clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest KMT2A Rearrangement clinical trials

StudyPhaseWhereStatusRegistered
Menin inhibitor maintenance after allogeneic stem cell transplant — Suzhou, Jiangsu Recruiting Apr 30, 2026
BN104 maintenance after allogeneic stem cell transplant for acute leukemia Phase 2 Suzhou, Jiangsu Recruiting Aug 3, 2025
Ziftomenib treatment after blood cancer transplant Phase 1 Boston, Massachusetts and 1 other locations Recruiting Jun 3, 2024

All recruiting trials (3)

Related topics

NPM1 MutationAcute LeukemiaMaintenance TherapyAcute Myeloid LeukemiaAcute Myeloid Leukemia in Remission

Quick answers

How many KMT2A Rearrangement clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.